Low Dose Naltrexone (LDN) is a novel approach to decrease the release of inflammatory substances, reduce nerve cell inflammation and autoimmune mediators.
May be selected for individuals with oral intolerance or heightened medication sensitivity. A topical preparation provides a non-oral option that avoids the digestive tract and may be incorporated into a broader, provider-directed care plan.